What is Vericel Corporation's Market Cap?

Vericel Corporation's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's Enterprise Value?

Vericel Corporation's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's Trailing P/E?

Vericel Corporation's Trailing P/E is 89.9×, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's Price / Sales?

Vericel Corporation's Price / Sales is 7.1×, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's EV / Revenue?

Vericel Corporation's EV / Revenue is 6.6×, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's EV / EBITDA?

Vericel Corporation's EV / EBITDA is 64.7×, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's Revenue (TTM)?

Vericel Corporation's Revenue (TTM) is $306.3M, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's Net Income (TTM)?

Vericel Corporation's Net Income (TTM) is $24.2M, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's EBITDA?

Vericel Corporation's EBITDA is $31.2M, based on as-reported figures from SEC (XBRL) filings.

What is Vericel Corporation's Diluted EPS (TTM)?

Vericel Corporation's Diluted EPS (TTM) is 0.47, based on as-reported figures from SEC (XBRL) filings.

AKYLA/ Financials

Equity / BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Vericel Corporation

XNAS · usd

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG001S6X9M3

42.53▼ 0.44 (-1.02%)

As of 2026-10-23

Price / Volume

Valuation

Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA

Financial Highlights

Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt

Trading Information

Previous Close: 42.97
Day's Range: 41.75 – 43.00
52-Week Range: 28.95 – 49.32
Volume: 494.7K
Avg Volume: 548.5K

Share Statistics

Shares Outstanding
Employees: 398
Exchange: XNAS
Listed: 1997-02-04

Share count as of July 24, 2026

Vericel Corporation (VCEL) Financial Statements

View

Income Statement

Detail

Standard

Period

Quarterly

Loading Income Statement…

Key questions about Vericel Corporation (VCEL)

What is Vericel Corporation's Market Cap?: Vericel Corporation's Market Cap is $2.2B, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Enterprise Value?: Vericel Corporation's Enterprise Value is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Trailing P/E?: Vericel Corporation's Trailing P/E is 89.9×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Price / Sales?: Vericel Corporation's Price / Sales is 7.1×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's EV / Revenue?: Vericel Corporation's EV / Revenue is 6.6×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's EV / EBITDA?: Vericel Corporation's EV / EBITDA is 64.7×, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Revenue (TTM)?: Vericel Corporation's Revenue (TTM) is $306.3M, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Net Income (TTM)?: Vericel Corporation's Net Income (TTM) is $24.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's EBITDA?: Vericel Corporation's EBITDA is $31.2M, based on as-reported figures from SEC (XBRL) filings.
What is Vericel Corporation's Diluted EPS (TTM)?: Vericel Corporation's Diluted EPS (TTM) is 0.47, based on as-reported figures from SEC (XBRL) filings.

Akyla / Financials · VCELAs-filed SEC (XBRL) data